BBIO Competitors & Alternatives
Compare BridgeBio Pharma Inc with similar stocks in the same industry
Biotechnology
BBIO
Main Stock$78.17
Tradestie Score
30
Market Cap
$10.22B
Revenue Growth
1.9%
Analyst Upside
+36.7%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$51.74
|
$19.56B | 46.0 | 33 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.70
|
$16.93B | 62.4 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$68.97
|
$15.70B | 45.8 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.08
|
$15.22B | - | 48 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$267.07
|
$12.36B | 19.9 | 36 | Compare |
|
EXEL
Exelixis Inc
|
$69.84
|
$11.09B | 21.2 | 27 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$39.99
|
$10.76B | - | 31 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$231.35
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.70
|
$10.53B | - | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$27.31
|
$10.49B | - | 45 | Compare |
More BBIO Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry